MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,560 | -66.7% | 12,000 | -7.7% | 0.00% | – |
| Q2 2023 | $4,680 | -29.9% | 13,000 | -8.5% | 0.00% | – |
| Q1 2023 | $6,674 | -60.7% | 14,200 | -54.5% | 0.00% | – |
| Q4 2022 | $17,000 | -19.0% | 31,200 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -12.5% | 31,200 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -4.0% | 31,200 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -19.4% | 31,200 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -8.8% | 31,200 | +19.1% | 0.00% | – |
| Q3 2021 | $34,000 | +100.0% | 26,200 | +18.0% | 0.00% | – |
| Q2 2021 | $17,000 | -26.1% | 22,200 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | -14.8% | 22,200 | +11.0% | 0.00% | – |
| Q4 2020 | $27,000 | +80.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | +200.0% | 20,000 | +233.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,923,000 | $509,990 | 0.12% |
| Arkadios Wealth Advisors | 1,399,000 | $181,870 | 0.02% |
| NEVILLE RODIE & SHAW INC | 1,157,332 | $150 | 0.01% |
| Platform Technology Partners | 162,410 | $21,113 | 0.01% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $101 | 0.01% |
| Main Street Financial Solutions, LLC | 400,826 | $52,107 | 0.01% |
| National Wealth Management Group, LLC | 42,750 | $5,558 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 400,000 | $52,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 754,732 | $98,115 | 0.00% |
| HYMAN CHARLES D | 79,800 | $10,000 | 0.00% |